Lange T, Bumm T, Otto S, Al-Ali H, Kovacs I, Krug D, Kohler T, Krahl R, Niederwieser D, Deininger M. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Haematologica [Internet]. 2004Jan.1 [cited 2026Oct.30];89(1):49-7. Available from: https://haematologica.org/article/view/2958